|
|
|
Volumn 25, Issue 4, 2005, Pages
|
|
Personalized arthritis therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
ETANERCEPT;
INFLIXIMAB;
INTERLEUKIN 1;
INTERLEUKIN 1 ANTIBODY;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
ROFECOXIB;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ARTICLE;
ATHEROSCLEROTIC PLAQUE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COMPUTER;
DISEASE PREDISPOSITION;
DRUG INDUSTRY;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GENE EXPRESSION PROFILING;
GENETIC DIFFERENCE;
HEART INFARCTION;
HUMAN;
MUSCULOSKELETAL SYSTEM INFLAMMATION;
OSTEOARTHRITIS;
OSTEOPOROSIS;
PHARMACOGENETICS;
PROCESS TECHNOLOGY;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
SCIENCE;
SINGLE NUCLEOTIDE POLYMORPHISM;
|
|
EID: 14644433125
PISSN: 02706377
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|